Literature DB >> 10500907

Pulmonary hypertension related to drugs and toxins.

L Abenhaim1, M Humbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10500907     DOI： 10.1097/00001573-199909000-00013

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN： 0268-4705            Impact factor:   2.161


× No keyword cloud information.
  4 in total

Review 1.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 2.  New approaches to the treatment of pulmonary hypertension: from bench to bedside.

Authors:  Subramanyam N Murthy; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644

3.  Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.

Authors:  Patricia N Sidharta; Paul L M van Giersbergen; Michael Wolzt; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  Thyrotoxicosis presenting as exertional dyspnea and pulmonary hypertension: Case report and review of literature.

Authors:  Farid Rashidi; Hossein Sate; Esmaeil Faraji; Sepideh Tahsini Tekantapeh
Journal:  SAGE Open Med Case Rep       Date:  2017-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.